^{19th International Conference on} Medicinal Chemistry & Multi Targeted Drug Delivery November 05-06, 2018 San Francisco, USA

Prof.Dr.Prakash is a Professor in the Department Of Chemistry at Sri Vidyanikethan Engineering college, Jawaharlal Lal Technological University, India. He was a NIH visiting fellow at Karmonas Cancer Research Institute, Wayne State University School Of Medicine. He was a Royal Society Visiting Scientist in the chemistry laboratories at the University of Oxford, UK He has published all his research in high impact international journals and Presented papers in International Conferences including American Chemical society Conferences. He has 33 International publications and 31 international conference presentations including American Chemical Society conferences.

Medicinal Chemistry, Drug Chemistry, Drug Delivery, Cancer studies

Alexei Basnakian received his PhD and DSc degrees from the Russian Academy of Medical Science, both in the field of DNA-degrading enzymes. He had postdoctoral trainings in molecular biology at the Harvard Medical School and in toxicology/cancer research at the National Center for Toxicological Research/U.S. Food and Drug Administration. Dr. Basnakian is a tenured Professor at the Department of Pharmacology and Toxicology, and Director of the DNA Damage and Toxicology Core Center at the University of Arkansas for Medical Sciences, and Research Career Scientist at the Veterans Hospital in Little Rock, Arkansas, USA. He is an author of 86 peer-reviewed papers and 14 reviews or book chapters. Dr. Basnakian is an Editorial Board member of several biomedical journals, and a member of NIH, AHA and VA grant study sections. His research interests are in DNases/endonucleases and DNA damage associated with toxicity, anti-cancer therapy, tissue injury and cell death.

DNases/endonucleases and DNA damage associated with toxicity, anti-cancer therapy, tissue injury and cell death.

Tatsuya TAKAGI has completed his Ph.D. at the age of 32 from Osaka University. At that time, he had been an Assistant Professor of School of Pharmaceutical Sciences, Osaka University for 5 years. Then, since 1993, he had worked for the Genome Information Research Center, Osaka University as an Associate Professor until he became a Professor of Graduate School of Pharmaceutical Sciences, Osaka University in 1998. He has published more than 150 papers in reputed journals and had served as Chairman of Division of Structure-Activity Relationship of the Pharmaceutical Society of Japan for three years (until March 2017)

Development or Revision of Computer Intensive Statistical Method for Pharmaceutical and Environmental Sciences; Application of Data Minig Method to Pharmaceutical and Environmental Sciences; Structure Based Drug Design for Infectional Diseases

Howard Alper is Distinguished University Professor at the University of Ottawa, and spearheads the bold Global Excellence Initiative launched by Canada’s former Head of State. HA serves as Chair of the Canvassing Committee for the initiative. He has published 552 papers, edited several books, and has 37 patents. He serves on Advisory Committees in industry, academia, and the NGO sector. He has served as the Chair of the Government of Canada’s Science, Technology, and Innovation Council from 2007-2015, and represented Canada for eight years to the Carnegie Group of Science Advisors to National Leaders (or Ministers of Science if the nation has no science advisor)

Organic and Biological Chemistry Inorganic and Organometallic Chemistry Catalysis Asymmetric synthesis Dendrimers Cyclization

Dr. Rais is an Assistant Professor of Neurology at the Johns Hopkins School of Medicine, and Director of the Drug Metabolism and Pharmacokinetics group of Johns Hopkins Drug Discovery (JHDD) (https://drugdiscovery.jhu.edu/). Prior to joining Johns Hopkins, she was granted a Research Science Regulatory (RSR) fellowship at US FDA to evaluate the biopharmaceutic properties of new molecular entities from new drug applications. She received her Ph.D. in Pharmaceutical Sciences with substantial experience in biopharmaceutics, drug transport, drug metabolism, pharmacokinetics, preclinical formulation, and prodrug synthesis and characterization. As a part of JHDD she has taken primary responsibility for leading the DMPK group, conducting drug discovery research and writing of over 50 peer reviewed articles in high impact journals. She has served as a consultant and provided research support to several pharmaceutical biotech companies including Transcept

Dr. Rais received her Ph.D. in Pharmaceutical Sciences with substantial experience in biopharmaceutics, drug permeability, drug transport, drug metabolism, pharmacokinetics, and drug delivery including prodrug design and characterization. Rana now leads a drug metabolism, pharmacokinetic, and bio analysis laboratory and directs this unit as part of the Johns Hopkins Drug Discovery program.